Page contentsPage contents Shortage information Key facts Key dates Related medicine information Direct healthcare professional communication related to this shortage Shortage information Natpar has now been discontinued and is no longer available. Key facts Medicines affected Natpar Supply shortage status Medicine discontinued International non-proprietary name (INN) or common name parathyroid hormone Therapeutic area (MESH) Hypoparathyroidism Pharmaceutical forms affected Powder and solvent for solution for injection Strengths affected 100 micrograms/dose 75 micrograms/dose 50 micrograms/dose 25 micrograms/dose Availability of alternatives Yes Key dates First published 02/05/2022 Last updated 09/09/2026 Related medicine information Natpar Information on shortages and national shortage registers Medicine Shortages Single Point of Contact (SPOC) Working Party National competent authorities (human) Eligible healthcare professionals' organisations Eligible patients and consumers' organisations Direct healthcare professional communication related to this shortageNatpar - direct healthcare professional communication (DHPC)Natpar - direct healthcare professional communication (DHPC) Share this page